As India's first mRNA vaccine is in advanced stages of clinical trials, Gennova Biopharmaceuticals tells NDTV how the vaccine is consistently being peer reviewed and how India could produce it by the end of this year.
from Videos https://ift.tt/3pi946F
No comments:
Post a Comment